Sometimes clinically, endoscopically, radiologically, and even histologically, it may be difficult to distinguish CD from intestinal TB.42 In such situations, empirical ATT is attempted.9 However, with increasing awareness about features that help in differentiating CD from TB and the availability of better tests for microbiological confirmation of intestinal TB [such as TB‐PCR, cartridge‐based nucleic acid amplification test (CB‐NAT or geneXpert)], the empirical use of ATT before starting immunosuppressive therapy in CD should decrease, but no study confirms this notion. Here, BRD2 is linked to tuberculosis.